Efficacy and Safety of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker in Acute Myocardial Infarction Patients: A Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Ananta, Muammar Emir [1 ]
Ivan, Ignatius [2 ]
Wijaya, Alya Darin [3 ]
Albab, Chabib Fachry [4 ]
Danny, Siska [5 ]
机构：
[1] Jakarta Islamic Hosp Cempaka Putih, Jakarta, Indonesia
[2] Atma Jaya Catholic Univ Indonesia, Jakarta, Indonesia
[3] UCL, London, England
[4] Alumnus Univ Airlangga, Surabaya, Indonesia
[5] Indonesian Soc Intervent Cardiol, Jakarta, Indonesia
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCTAP A-03
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [1] The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
    Kotak, Sohny
    Hassan, Warda
    Mehmood, Marium
    Kumar, Umesh
    Sagreeka, Fnu
    Karishma, Fnu
    Kumari, Pirya
    Pirya, Fnu
    Saquib, Javeria
    Iqbal, Amna
    Khan, Anosh Aslam
    Varrassi, Giustino
    Khatri, Mahima
    Kumar, Satesh
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [2] Renal safety and efficacy of angiotensin receptor-neprilysin inhibitor: A meta-analysis of randomized controlled trials
    Feng, Yu
    Yin, Yongmei
    Deng, Rong
    Li, Haonan
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (06) : 1235 - 1243
  • [3] Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: A systematic review and meta-analysis of Randomized controlled trials
    Lakhdar, Rachid
    Al-Mallah, Mouaz H.
    Lanfear, David E.
    [J]. JOURNAL OF CARDIAC FAILURE, 2008, 14 (03) : 181 - 188
  • [4] Comparative efficacy of angiotensin converting enzyme inhibitor and angiotensin receptor blocker for patients with acute myocardial infarction and renal dysfunction
    Won, J.
    Jeong, H. K.
    Hong, Y. J.
    Jeong, M. H.
    Kim, Y. J.
    Chae, S. C.
    Hong, T. J.
    Seong, I. W.
    Chae, J. K.
    Kim, C. J.
    Cho, M. C.
    Rha, S. W.
    Bae, J. H.
    Seung, K. B.
    Park, S. J.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 1360 - 1360
  • [5] Comparative Efficacy of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker for Patients With Acute Myocardial Infarction and Renal Dysfunction
    Won, Jumin
    Hong, Young Joon
    Jeong, Myung Ho
    Jeong, Hyung Ki
    Kim, Young Jo
    Chae, Shung Chull
    Hong, Taek Jong
    Seong, In Whan
    Chae, Jei Keon
    Kim, Chong Jin
    Cho, Myeong Chan
    Rha, Seung-Woon
    Bae, Jang Ho
    Seung, Ki Bae
    Park, Seung Jung
    [J]. CIRCULATION, 2017, 136
  • [6] Kidney Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor vs Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy for Thrombotic Microangiopathy
    Li, Jianbo
    Liu, Qinghua
    Lian, Xingji
    Yang, Shicong
    Lian, Rong
    Li, Wenchuan
    Yu, Jianwen
    Huang, Fengxian
    Chen, Wenfang
    He, Feng
    Chen, Wei
    [J]. JAMA NETWORK OPEN, 2024, 7 (09)
  • [7] Meta-analysis of prevention of myocardial infarction by angiotensin converting enzyme inhibitor and angiotensin receptor blocker in relation to change in blood pressure
    Fujisawa, Tomomi
    Ogihara, Toshio
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 : 327 - 327
  • [8] Angiotensin Receptor-Neprilysin Inhibitor Effects on Atherosclerotic Cardiovascular Disease Events: A Meta-Analysis of Randomized Controlled Trials
    Ravani, Lis Victoria
    Gewehr, Douglas Mesadri
    Calomeni, Pedro
    Gauza, Mateus de Miranda
    Pereira, Jussara
    Cardoso, Rhanderson
    Ribeiro, Henrique Barbosa
    Bocchi, Edimar
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2023, 205 : 259 - 268
  • [9] Efficacy and safety of angiotensin-converting enzyme inhibitors/angiotensin receptor blocker therapy for IgA nephropathy: A meta-analysis of randomized controlled trials
    Ji, Yue
    Yang, Kang
    Xiao, Bo
    Lin, Jin
    Zhao, Qingyun
    Bhuva, Maheshkumar Satishkumar
    Yang, Hongtao
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 3689 - 3695
  • [10] First dose hypotension after angiotensin converting enzyme inhibitor and angiotensin II receptor blocker in patients with acute myocardial infarction
    Spinar, J
    Vitovec, J
    Pluhacek, I
    Spinarova, L
    Fisherova, B
    Toman, J
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 : S211 - S211
12345